Lesinurad

雷西纳德

Report date: 2022/08/19 20:00:31
NME

Base Information

Drug NameLesinurad
Drug Alias Name来司诺雷lesinuradum来西努雷来辛奴拉Zurampic +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSolute carrier family 22 member 11 inhibitorsUric acid transporter 1 inhibitors
TargetsUric acid transporter 1Solute carrier family 22 member 11
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsHyperuricemiaGout
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2015/12/22
Country/TerritoryCzechiaBelgiumBulgaria +[16] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrunenthal GmbhArdea Biosciences IncIronwood Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHyperuricemiaGout

Other Information

ATC CodeM04AB05
Related LinksWikipediaDrugBankKEGG